Sodium chloride 5% solution
DrugUse Sodium chloride 5% solution with usual anti microbial drugs
NCT Number: NCT07452588
This study aims to detect the effect of sodium chloride 5% solution as an adjuvant treatment with antimicrobial therapy in treatment of bacterial infectious keratits and to assess whether NaCl 5% accelerates epithelial healing, improves microbial eradication, and enhances visual outcomes in bacterial infectious keratitis.
Trial opening soon.
Get Notified18 year–60 year
All sexes
Interventional
Not applicable
Prospective randomized control study to detect the effect of sodium chloride 5% solution as an adjuvant treatment with antimicrobial therapy in treatment of bacterial infectious keratits and to assess whether NaCl 5% accelerates epithelial healing, improves microbial eradication, and enhances visual outcomes in bacterial infectious keratitis.Data study will include two groups classified as follow : the first group will include treatment of microbial keratitis by antibiotic with sodium chloride 5% , the second group will include treatment by antibiotic only
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
IncluInclusion Criteria
Exclusion criteria
Use Sodium chloride 5% solution with usual anti microbial drugs
Use of usual topical anti microbial treatment only
Time frame: 6 months
Improvement of manifestation according to rate of healing
Contact information is provided by the study sponsor or research team.
Amr Mounir Mohamed, Assistant professor
CONTACT
Nancy Safwat Kaldas, Specialist
CONTACT
Sohag University
Other
Acronym: keratitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02570321
Bacterial Ulcer, Corneal Diseases
San Francisco, California, United States
View Trial DetailsNCT05888987
Corneal Infection, Infectious Keratitis
Reims, France
View Trial DetailsNCT06539663
Corneal Diseases, Corneal Injuries
Kuwait City, Kuwait
View Trial DetailsNCT06364878
Infectious Keratitis
Arendal, Norway
View Trial Details